Inhibiting NUFR1 promotes ferroptosis by downregulating expression of lipocalin 2 (LCN2), increasing the intracellular iron concentration, decreasing lipid peroxidation, and decreasing DNA oxidative damage
They were approved for therapy by the FDA and EMA in 2014, although albiglutide was withdrawn from the market in 2018 for economic reasons
The researchers didnt account for income, exercise, alcohol use, family history, genetic risk, or other medications
Research-Only Status in the U.S
Ive always been a pretty transparent person, probably because I grew up on the very public tennis court in front of millions of people
Six out of 7 completers were included in the final evaluation for receptor occupancy, one patient had a major protocol deviation (dosing titration irregularity) and was excluded from this analysis